OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia
Morgan E. Wallace, Marice Alcantara, Yosuke Minoda, et al.
International Immunopharmacology (2015) Vol. 28, Iss. 2, pp. 897-900
Closed Access | Times Cited: 16

Showing 16 citing articles:

Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies
Giovanni D’Arena, Candida Vitale, Marta Coscia, et al.
Journal of Immunology Research (2017) Vol. 2017, pp. 1-13
Open Access | Times Cited: 40

The double-edge role of B cells in mediating antitumor T-cell immunity: Pharmacological strategies for cancer immunotherapy
Jing-Zhang Wang, Yuhua Zhang, Xinhua Guo, et al.
International Immunopharmacology (2016) Vol. 36, pp. 73-85
Closed Access | Times Cited: 36

Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition
Mérédis Favreau, Koen Venken, Sylvia Faict, et al.
Haematologica (2017) Vol. 102, Iss. 7, pp. e266-e270
Open Access | Times Cited: 30

Emerging role of BCR signaling inhibitors in immunomodulation of chronic lymphocytic leukemia
Kamira Maharaj, Eva Sahakian, Javier Pinilla‐Ibarz
Blood Advances (2017) Vol. 1, Iss. 21, pp. 1867-1875
Open Access | Times Cited: 22

Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia
Candida Vitale, Elia Boccellato, Lorenzo Comba, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3856-3856
Open Access | Times Cited: 16

Mucosal-associated invariant T cells in clinical diseases.
Rangsima Reantragoon, Norasate Boonpattanaporn, Alexandra J. Corbett, et al.
PubMed (2016) Vol. 34, Iss. 1, pp. 3-10
Closed Access | Times Cited: 18

Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes
Barbara Sherry, Preetesh Jain, Pui Yan Chiu, et al.
Immunologic Research (2015) Vol. 63, Iss. 1-3, pp. 216-227
Open Access | Times Cited: 15

A potentially important role for T cells and regulatory T cells in Langerhans cell histiocytosis
Jenée Mitchell, Stuart P. Berzins, George Kannourakis
Clinical Immunology (2018) Vol. 194, pp. 19-25
Closed Access | Times Cited: 14

Cross‐talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review
Saeid Taghiloo, Hossein Asgarian‐Omran
European Journal Of Haematology (2024) Vol. 113, Iss. 1, pp. 4-15
Open Access | Times Cited: 1

Targeting the tumor promoting effects of adenosine in chronic lymphocytic leukemia
Yiqing Cai, Lili Feng, Xin Wang
Critical Reviews in Oncology/Hematology (2018) Vol. 126, pp. 24-31
Closed Access | Times Cited: 12

Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia
Yanyan Liu, Yongping Song, Qingsong Yin
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7

RETRACTED: Elevated levels of follicular T helper cells and their association with therapeutic effects in patients with chronic lymphocytic leukaemia
Liannv Qiu, Yonglie Zhou, Qinhua Yu, et al.
Immunology Letters (2018) Vol. 197, pp. 15-28
Closed Access | Times Cited: 6

Immune characteristics and prognostic implications of mucosal-associated invariant T cells in acute myeloid leukemia
Peng Qian, Renhua Huang, Huiping Wang, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 4399-4414
Open Access | Times Cited: 1

T Regulatory Cells in Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with High Dose Methylprednisolone and Rituximab
Regina Pileckytė, Regina Pileckytė, Tadas Žvirblis, et al.
Clinical Oncology and Research (2020), pp. 1-6
Open Access

Description of invariant NKT cells.
Katarzyna Karwicka, Aneta Szudy‐Szczyrek, Marek Hus
Journal of Education Health and Sport (2021) Vol. 11, Iss. 9, pp. 417-422
Open Access

Page 1

Scroll to top